TLR2 and cancer: Knockdown of TLR2 markedly reduced the invasive capability of the high-metastatic cancer cell lines, including A549, H7402, HCT8 and MDA-MB231, but did not affect the invasive activity of the low-metastatic cell MCF7 (Fig. 1E).